Pharmaceutical Trade Challenges and U.S. Policy Implications

This chapter examines the omission of active pharmaceuticals from recent trade discussions and the resulting challenges for U.S. dependence on these vital products. It highlights the need for comprehensive supply chain strategies beyond tariffs, including potential subsidies, while addressing the low profit margins in the pharmaceutical sector. The discussion also situates these issues within the broader context of U.S.-China trade relations and the political ramifications of trade policy decisions.